eNOS antibody
GTX133404
ApplicationsWestern Blot
Product group Antibodies
ReactivityHuman
TargetNOS3
Overview
- SupplierGeneTex
- Product NameeNOS antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.93 mg/ml
- ConjugateUnconjugated
- Gene ID4846
- Target nameNOS3
- Target descriptionnitric oxide synthase 3
- Target synonymsECNOS, eNOS, nitric oxide synthase 3, EC-NOS, NOS type III, NOSIII, cNOS, constitutive NOS, endothelial NOS, nitric oxide synthase 3 (endothelial cell)
- HostRabbit
- IsotypeIgG
- Protein IDP29474
- Protein NameNitric oxide synthase 3
- Scientific DescriptionNitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq]
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Chen SF, Lee CL, Kuo HC. Changes in sensory proteins in the bladder urothelium of patients with chronic kidney disease and end-stage renal disease. Low Urin Tract Symptoms. 2019,11(2):O202-O208. doi: 10.1111/luts.12240Read this paper
- Chen SF, Jiang YH, Kuo HC. Single onabotulinumtoxinA 200U dose improved clinical symptoms but not urothelial dysfunction in neurogenic detrusor overactivity due to spinal cord injury. J Formos Med Assoc. 2019,118(1 Pt 1):125-133. doi: 10.1016/j.jfma.2018.02.002Read this paper




![IHC-P analysis of human stomach cancer (left) and ovary cancer (right) tissue using GTX83305 eNOS antibody [6H2].](https://www.genetex.com/upload/website/prouct_img/normal/GTX83305/GTX83305_20170912_IHC-P_1_w_23061322_913.webp)